Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases
Disease Category: Atrial Fibrillation
Location: United States, TX
Clinical Trial Details
Research Study Summary
Atrial Fibrillation - Houston, TX
The primary objective of this study is to determine if apixaban is noninferior to warfarin in the endpoint of stroke and systemic embolism in individuals with AF
Patient Inclusion Criteria: Must be at least 18 years of age or older and have atrial fibrillation or atrial flutter
Patient Exclusion Criteria: Can not have atrial fibrillation or flutter due to reversible causes (ie thyrotoxicosis, pericarditis). Can not have clinically significant mitral stenosis. Can not have persistent and uncontrolled hypertension.
To Learn more
Both Male and Female
Date Last Changed:
July 24, 2013
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.